Inhibition of reactive gliosis attenuates excitotoxicity-mediated death of retinal ganglion cells

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Ganesh, Bhagyalaxmi S ^a   Chintala, Shravan K ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOADIPIC ACID; GANGLION AFFECTING AGENT; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROSTATIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE; VIMENTIN; GLYCOSPHINGOLIPID; KAINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME DEGRADATION; EXCITOTOXICITY; GLIOSIS; IMMUNOHISTOCHEMISTRY; MOUSE; MUELLER CELL; NERVE CELL NECROSIS; NICK END LABELING; NONHUMAN; RETINA GANGLION CELL; ZYMOGRAPHY; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; IN VITRO STUDY; METABOLISM; PATHOLOGY; RETINA;

MUS;

2-AMINOADIPIC ACID; ANIMALS; APOPTOSIS; GLIOSIS; GLYCOSPHINGOLIPIDS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KAINIC ACID; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; RETINA; RETINAL GANGLION CELLS; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 79953658906     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018305     Document Type: Article

References (33)

1. Halassa MM, Fellin T, Haydon PG, (2007) The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med 13: 54-63.
2. Halassa MM, Fellin T, Haydon PG, (2009) Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology 57: 343-346.
3. Neufeld AH, Liu B, (2003) Glaucomatous optic neuropathy: when glia misbehave. Neuroscientist 9: 485-495.
4. Radany EH, Brenner M, Besnard F, Bigornia V, Bishop JM, et al. (1992) Directed establishment of rat brain cell lines with the phenotypic characteristics of type 1 astrocytes. Proc Natl Acad Sci U S A 89: 6467-6471.
5. Miller RH, Fulton BP, Raff MC, (1989) A Novel Type of Glial Cell Associated with Nodes of Ranvier in Rat Optic Nerve. Eur J Neurosci 1: 172-180.
6. Belliveau DJ, Naus CC, (1994) Cortical type 2 astrocytes are not dye coupled nor do they express the major gap junction genes found in the central nervous system. Glia 12: 24-34.
7. Hernandez MR, (2000) The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res 19: 297-321.
8. Hernandez MR, Miao H, Lukas T, (2008) Astrocytes in glaucomatous optic neuropathy. Prog Brain Res 173: 353-373.
9. Inman DM, Horner PJ, (2007) Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma. Glia 55: 942-953.
10. Johnson EC, Deppmeier LM, Wentzien SK, Hsu I, Morrison JC, (2000) Chronology of optic nerve head and retinal responses to elevated intraocular pressure. Invest Ophthalmol Vis Sci 41: 431-442.
11. Johnson EC, Morrison JC, (2009) Friend or foe? Resolving the impact of glial responses in glaucoma. J Glaucoma 18: 341-353.
12. Yuan L, Neufeld AH, (2000) Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 32: 42-50.
13. Nakazawa T, Matsubara A, Noda K, Hisatomi T, She H, et al. (2006) Characterization of cytokine responses to retinal detachment in rats. Mol Vis 12: 867-878.
14. Prasanna G, Krishnamoorthy R, Clark AF, Wordinger RJ, Yorio T, (2002) Human optic nerve head astrocytes as a target for endothelin-1. Invest Ophthalmol Vis Sci 43: 2704-2713.
15. Yorio T, Krishnamoorthy R, Prasanna G, (2002) Endothelin: is it a contributor to glaucoma pathophysiology? J Glaucoma 11: 259-270.
16. Zhang X, Cheng M, Chintala SK, (2004) Optic nerve ligation leads to astrocyte-associated matrix metalloproteinase-9 induction in the mouse retina. Neurosci Lett 356: 140-144.
17. Zhang X, Cheng M, Chintala SK, (2004) Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration. Invest Ophthalmol Vis Sci 45: 2374-2383.
18. Zhang X, Chaudhry A, Chintala SK, (2003) Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage. Mol Vis 9: 238-248.
19. Mali RS, Cheng M, Chintala SK, (2005) Plasminogen activators promote excitotoxicity-induced retinal damage. FASEB J 19: 1280-1289.
20. Johnson TV, Bull ND, Martin KR, (2010) Identification of barriers to retinal engraftment of transplanted stem cells. Invest Ophthalmol Vis Sci 51: 960-970.
21. West EL, Pearson RA, Tschernutter M, Sowden JC, MacLaren RE, et al. (2008) Pharmacological disruption of the outer limiting membrane leads to increased retinal integration of transplanted photoreceptor precursors. Exp Eye Res 86: 601-611.
22. Ishikawa Y, Mine S, (1983) Aminoadipic acid toxic effects on retinal glial cells. Jpn J Ophthalmol 27: 107-118.
23. Hefti F, Hartikka J, Frick W, (1985) Gangliosides alter morphology and growth of astrocytes and increase the activity of choline acetyltransferase in cultures of dissociated septal cells. J Neurosci 5: 2086-2094.
24. Abad-Rodriguez J, Bernabe M, Romero-Ramirez L, Vallejo-Cremades M, Fernandez-Mayoralas A, et al. (2000) Purification and structure of neurostatin, an inhibitor of astrocyte division of mammalian brain. J Neurochem 74: 2547-2556.
25. Anderson DR, Hoyt WF, Hogan MJ, (1967) The fine structure of the astroglia in the human optic nerve and optic nerve head. Trans Am Ophthalmol Soc 65: 275-305.
26. Kim JH, Park JA, Lee SW, Kim WJ, Yu YS, et al. (2006) Blood-neural barrier: intercellular communication at glio-vascular interface. J Biochem Mol Biol 39: 339-345.
27. Kuehn MH, Kim CY, Ostojic J, Bellin M, Alward WL, et al. (2006) Retinal synthesis and deposition of complement components induced by ocular hypertension. Exp Eye Res 83: 620-628.
28. Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter ML, (2006) Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci 47: 977-985.
29. Pena JD, Agapova O, Gabelt BT, Levin LA, Lucarelli MJ, et al. (2001) Increased elastin expression in astrocytes of the lamina cribrosa in response to elevated intraocular pressure. Invest Ophthalmol Vis Sci 42: 2303-2314.
30. Chintala SK, Zhang X, Austin JS, Fini ME, (2002) Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J Biol Chem 277: 47461-47468.
31. Kumada M, Niwa M, Wang X, Matsuno H, Hara A, et al. (2004) Endogenous tissue type plasminogen activator facilitates NMDA-induced retinal damage. Toxicol Appl Pharmacol 200: 48-53.
32. Harvey R, Chintala SK, (2007) Inhibition of plasminogen activators attenuates the death of differentiated retinal ganglion cells and stabilizes their neurite network in vitro. Invest Ophthalmol Vis Sci 48: 1884-1891.
33. Nadal-Nicolas FM, Jimenez-Lopez M, Sobrado-Calvo P, Nieto-Lopez L, Canovas-Martinez I, et al. (2009) Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophthalmol Vis Sci 50: 3860-3868.